29:
229:
206:
183:
793:
648:
730:
702:
411:
798:
788:
368:
acquired a 20% stake in
Concord Biotech in 2016. Jhunjhunwala's Rare Enterprises holds 24% stake in the company. Quadria Capital sold its entire stake in Concord Biotech's 2023
773:
547:
467:
358:-based Matrix Laboratories acquired 55% stake in the company, by buying partial shareholding of Vaid and Jhunjhunwala. After Matrix Laboratories was acquired by
783:
623:
763:
499:
572:
768:
778:
803:
597:
524:
676:
198:
56:
324:
369:
381:
296:
65:
343:. It was the first company in India and the second in the world to develop an anti-immuno suppressant
340:
351:
436:
735:
707:
653:
60:
576:
289:
286:
171:
680:
365:
69:
328:
167:
39:
362:, the latter sold back its stake in Concord Biotech to Vaid and Jhunjhunwala in 2009.
757:
308:
274:
82:
47:
28:
312:
282:
412:"Concord Biotech consolidated net profit rises 3.86% in the March 2024 quarter"
344:
304:
221:
355:
320:
278:
163:
109:
295:
It manufactures biopharmaceutical products across therapy segments such as
339:
Concord
Biotech was founded in 2000 by Sudhir Vaid, a former director at
300:
468:"Jhunjhunwala backed Concord Biotech sets IPO price band at Rs 705-741"
113:
703:"Rakesh Jhunjhunwala to give up Concord Biotech stake, eyes Rs 500 cr"
386:
316:
359:
257:
731:"Domestic pharmaceutical players eye Bharat Serums acquisition"
649:"Quadria Cap concludes Rs 475.31 crore investment in Concord"
548:"Concord Biotech's niche API play holds promise for growth"
500:"Actis in talks to buy minority stake in Concord Biotech"
794:
Companies listed on the
National Stock Exchange of India
354:acquired around 14% stake in the company. In 2005,
252:
242:
219:
196:
177:
159:
134:
124:
104:
96:
88:
78:
45:
35:
799:Companies listed on the Bombay Stock Exchange
8:
789:Pharmaceutical companies established in 2000
21:
573:"Concord Biotech eyes 5-fold growth by '06"
774:Manufacturing companies based in Ahmedabad
27:
20:
546:Somvanshi, Kiran Kabtta (4 August 2023).
498:Balakrishnan, Reghu (23 September 2015).
315:. It has two manufacturing facilities–at
598:"Matrix takes 55% stake in Concord Bio"
493:
491:
489:
398:
729:Balakrishnan, Reghu (30 August 2018).
677:"Quadria to invest in Concord Biotech"
624:"Mylan sells stake in Concord Biotech"
462:
460:
406:
404:
402:
7:
784:Indian companies established in 2000
525:"Concord Biotech mulling new unit"
14:
764:Pharmaceutical companies of India
622:Dutta, Vishal (8 December 2009).
290:active pharmaceutical ingredients
769:Biotechnology companies of India
228:
227:
205:
204:
182:
181:
701:Poddar, Nisha (16 March 2015).
779:2000 establishments in Gujarat
437:"Annual Report : FY21-22"
1:
804:2023 initial public offerings
271:Concord Biotech Limited (CBL)
192:(US$ 120 million) (FY24)
238:(US$ 37 million) (FY24)
215:(US$ 56 million) (FY24)
16:Indian biotechnology company
281:. The company manufactures
820:
277:company headquartered in
26:
370:initial public offering
323:, which is approved by
292:(APIs) sold worldwide.
341:Ranbaxy Laboratories
327:, and at Limbasi in
527:. Business Standard
382:Divi's Laboratories
352:Rakesh Jhunjhunwala
244:Number of employees
145:(Chairman & MD)
23:
736:The Economic Times
708:The Economic Times
654:The Economic Times
628:The Economic Times
552:The Economic Times
602:Business Standard
577:Business Standard
416:Business Standard
297:immunosuppressant
287:biopharmaceutical
268:
267:
172:Active ingredient
152:
146:
811:
748:
747:
745:
743:
726:
720:
719:
717:
715:
698:
692:
691:
689:
687:
673:
667:
666:
664:
662:
645:
639:
638:
636:
634:
619:
613:
612:
610:
608:
594:
588:
587:
585:
583:
569:
563:
562:
560:
558:
543:
537:
536:
534:
532:
521:
515:
514:
512:
510:
495:
484:
483:
481:
479:
464:
455:
454:
452:
450:
441:
433:
427:
426:
424:
422:
408:
264:
261:
259:
237:
235:
231:
230:
214:
212:
208:
207:
199:Operating income
191:
189:
185:
184:
150:
144:
31:
24:
819:
818:
814:
813:
812:
810:
809:
808:
754:
753:
752:
751:
741:
739:
728:
727:
723:
713:
711:
700:
699:
695:
685:
683:
675:
674:
670:
660:
658:
647:
646:
642:
632:
630:
621:
620:
616:
606:
604:
596:
595:
591:
581:
579:
571:
570:
566:
556:
554:
545:
544:
540:
530:
528:
523:
522:
518:
508:
506:
497:
496:
487:
477:
475:
466:
465:
458:
448:
446:
444:Concord Biotech
439:
435:
434:
430:
420:
418:
410:
409:
400:
395:
378:
366:Quadria Capital
337:
260:.concordbiotech
256:
245:
233:
232:
224:
210:
209:
201:
187:
186:
170:
168:Small molecules
166:
155:
137:
127:
120:
116:
74:
50:
22:Concord Biotech
17:
12:
11:
5:
817:
815:
807:
806:
801:
796:
791:
786:
781:
776:
771:
766:
756:
755:
750:
749:
721:
693:
668:
640:
614:
589:
564:
538:
516:
485:
474:. 31 July 2023
456:
428:
397:
396:
394:
391:
390:
389:
384:
377:
374:
336:
333:
329:Kheda district
266:
265:
254:
250:
249:
246:
243:
240:
239:
225:
220:
217:
216:
202:
197:
194:
193:
179:
175:
174:
161:
157:
156:
154:
153:
147:
140:
138:
135:
132:
131:
128:
125:
122:
121:
118:
108:
106:
102:
101:
98:
94:
93:
90:
86:
85:
80:
76:
75:
73:
72:
63:
53:
51:
46:
43:
42:
37:
33:
32:
15:
13:
10:
9:
6:
4:
3:
2:
816:
805:
802:
800:
797:
795:
792:
790:
787:
785:
782:
780:
777:
775:
772:
770:
767:
765:
762:
761:
759:
738:
737:
732:
725:
722:
710:
709:
704:
697:
694:
682:
678:
672:
669:
657:. 5 July 2016
656:
655:
650:
644:
641:
629:
625:
618:
615:
603:
599:
593:
590:
578:
574:
568:
565:
553:
549:
542:
539:
526:
520:
517:
505:
501:
494:
492:
490:
486:
473:
469:
463:
461:
457:
445:
438:
432:
429:
417:
413:
407:
405:
403:
399:
392:
388:
385:
383:
380:
379:
375:
373:
371:
367:
363:
361:
357:
353:
348:
346:
342:
334:
332:
330:
326:
322:
318:
314:
310:
309:antibacterial
306:
302:
298:
293:
291:
288:
284:
280:
276:
275:biotechnology
273:is an Indian
272:
263:
255:
251:
247:
241:
226:
223:
218:
203:
200:
195:
180:
176:
173:
169:
165:
162:
158:
148:
142:
141:
139:
133:
129:
123:
115:
111:
107:
103:
99:
95:
91:
87:
84:
83:Biotechnology
81:
77:
71:
67:
64:
62:
58:
55:
54:
52:
49:
44:
41:
38:
34:
30:
25:
19:
740:. Retrieved
734:
724:
712:. Retrieved
706:
696:
684:. Retrieved
671:
659:. Retrieved
652:
643:
631:. Retrieved
627:
617:
605:. Retrieved
601:
592:
580:. Retrieved
567:
555:. Retrieved
551:
541:
529:. Retrieved
519:
507:. Retrieved
503:
476:. Retrieved
472:Moneycontrol
471:
447:. Retrieved
443:
431:
419:. Retrieved
415:
364:
349:
338:
313:anthelmintic
294:
283:fermentation
270:
269:
248:1,180 (2022)
143:Sudhir Vaid
105:Headquarters
36:Company type
18:
582:28 February
449:17 December
190:1,016 crore
149:Ankur Vaid
126:Area served
100:Sudhir Vaid
758:Categories
686:18 January
531:5 February
393:References
345:tacrolimus
305:antifungal
222:Net income
136:Key people
61:CONCORDBIO
742:30 August
356:Hyderabad
350:In 2004,
321:Ahmedabad
279:Ahmedabad
236:308 crore
213:466 crore
164:Biologics
130:Worldwide
110:Ahmedabad
48:Traded as
714:16 March
376:See also
301:oncology
160:Products
79:Industry
478:31 July
335:History
285:-based
253:Website
178:Revenue
114:Gujarat
97:Founder
89:Founded
68::
59::
661:5 July
633:24 May
607:24 May
557:24 May
509:24 May
421:24 May
387:Biocon
317:Dholka
70:543960
40:Public
440:(PDF)
360:Mylan
325:USFDA
319:near
151:(CEO)
119:India
744:2018
716:2015
688:2016
681:Mint
663:2016
635:2024
609:2024
584:2013
559:2024
533:2013
511:2024
504:mint
480:2023
451:2022
423:2024
311:and
262:.com
92:2000
258:www
66:BSE
57:NSE
760::
733:.
705:.
679:.
651:.
626:.
600:.
575:.
550:.
502:.
488:^
470:.
459:^
442:.
414:.
401:^
372:.
347:.
331:.
307:,
303:,
299:,
117:,
112:,
746:.
718:.
690:.
665:.
637:.
611:.
586:.
561:.
535:.
513:.
482:.
453:.
425:.
234:₹
211:₹
188:₹
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
